Dolutegravir plus lamivudine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dolutegravir plus lamivudine, covering 2020-06-02 to 2020-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO) [Phase 3]